+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Retinitis Pigmentosa (Retinitis) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4768222
  • Report
  • April 2019
  • Region: Global
  • 66 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Allergan Plc
  • CMAX
  • Dompe Farmaceutici SpA
  • Horama SA
  • Innovations In Sight LLC
  • jCyte Inc
  • MORE
The global clinical trial report- “2019 Retinitis Pigmentosa (Retinitis) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Retinitis Pigmentosa (Retinitis). It presents in-depth analysis of Retinitis Pigmentosa (Retinitis) clinical trials across markets and companies. The research work is for providing complete understanding into trends in Retinitis Pigmentosa (Retinitis).

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Retinitis Pigmentosa (Retinitis) clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Retinitis Pigmentosa (Retinitis)

The research work is prepared through extensive and continuous research on Retinitis Pigmentosa (Retinitis) trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Retinitis Pigmentosa (Retinitis) patients are identified
  • The report includes panorama of Retinitis Pigmentosa (Retinitis) clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Retinitis Pigmentosa (Retinitis) clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Allergan Plc
  • CMAX
  • Dompe Farmaceutici SpA
  • Horama SA
  • Innovations In Sight LLC
  • jCyte Inc
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Retinitis Pigmentosa (Retinitis) Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Retinitis Pigmentosa (Retinitis) Clinical Trials by Region
2.2.2 Average Enrollment of Retinitis Pigmentosa (Retinitis) Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Retinitis Pigmentosa (Retinitis) Treatment, 2019

3. Region wise Retinitis Pigmentosa (Retinitis) Clinical Trials
3.1 Asia Pacific Retinitis Pigmentosa (Retinitis) Clinical Trials by Country
3.2 Europe Retinitis Pigmentosa (Retinitis) Clinical Trials by Country
3.3 North America Retinitis Pigmentosa (Retinitis) Clinical Trials by Country
3.4 Middle East and Africa Retinitis Pigmentosa (Retinitis) Clinical Trials by Country
3.5 South and Central America Retinitis Pigmentosa (Retinitis) Clinical Trials by Country

4. Retinitis Pigmentosa (Retinitis) Clinical Trial Trends
4.1 Start Year wise Retinitis Pigmentosa (Retinitis) Clinical Trials
4.2 Phase wise Retinitis Pigmentosa (Retinitis) Clinical Trials
4.3 Trial Status wise Retinitis Pigmentosa (Retinitis) Clinical Trials
4.4 Trial Type wise Retinitis Pigmentosa (Retinitis) Clinical Trials

5. Retinitis Pigmentosa (Retinitis) Average Enrollment Trends
5.1 Average Enrollment in Retinitis Pigmentosa (Retinitis) Trials by Year
5.2 Average Enrollment in Retinitis Pigmentosa (Retinitis) Trials by Phase
5.3 Average Enrollment in Retinitis Pigmentosa (Retinitis) Trials by Status
5.4 Average Enrollment in Retinitis Pigmentosa (Retinitis) Trials by Type of Trial

6. Companies Participating in Retinitis Pigmentosa (Retinitis) Clinical Trials
6.1 Retinitis Pigmentosa (Retinitis) Trials by Sponsor Type
6.2 Retinitis Pigmentosa (Retinitis) Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Retinitis Pigmentosa (Retinitis) Trials- Phase 1
7.2 Retinitis Pigmentosa (Retinitis) Trials- Phase 2
7.3 Retinitis Pigmentosa (Retinitis) Trials- Phase 3
7.4 Retinitis Pigmentosa (Retinitis) Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Retinitis Pigmentosa (Retinitis) Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Retinitis Pigmentosa (Retinitis) Clinical Trials and Enrolment
Figure 5: Europe - Country wise Retinitis Pigmentosa (Retinitis) Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Retinitis Pigmentosa (Retinitis) Clinical Trials and Enrolment
Figure 7: North America - Country wise Retinitis Pigmentosa (Retinitis) Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Retinitis Pigmentosa (Retinitis) Clinical Trials and Enrolment
Figure 9: Retinitis Pigmentosa (Retinitis) Clinical Trials by Phase
Figure 10: Retinitis Pigmentosa (Retinitis) Clinical Trials by Trial Status
Figure 11: Retinitis Pigmentosa (Retinitis) Clinical Trials by Type
Figure 12: Retinitis Pigmentosa (Retinitis) Clinical Trials by Sponsor Type
Figure 13: Retinitis Pigmentosa (Retinitis) Clinical Trials by Leading Sponsors
Figure 14: Retinitis Pigmentosa (Retinitis) Average Enrollment by Phase
Figure 15: Retinitis Pigmentosa (Retinitis) Average Enrollment by Trial Status
Figure 16: Retinitis Pigmentosa (Retinitis) Average Enrollment by Type
Figure 17: Retinitis Pigmentosa (Retinitis)- Average Enrolment by Type of Sponsors
Figure 18: Retinitis Pigmentosa (Retinitis)- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Retinitis Pigmentosa (Retinitis) Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Retinitis Pigmentosa (Retinitis) Clinical Trials and Enrolment
Table 5: Europe - Country wise Retinitis Pigmentosa (Retinitis) Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Retinitis Pigmentosa (Retinitis) Clinical Trials and Enrolment
Table 7: North America - Country wise Retinitis Pigmentosa (Retinitis) Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Retinitis Pigmentosa (Retinitis) Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Retinitis Pigmentosa (Retinitis) Average Enrollment by Phase
Table 15: Retinitis Pigmentosa (Retinitis) Average Enrollment by Trial Status
Table 16: Retinitis Pigmentosa (Retinitis) Average Enrollment by Type
Table 17: Retinitis Pigmentosa (Retinitis)- Average Enrolment by Type of Sponsors
Table 18: Retinitis Pigmentosa (Retinitis)- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Allergan Plc
  • CMAX
  • Dompe Farmaceutici SpA
  • Horama SA
  • Innovations In Sight LLC
  • jCyte Inc
  • Nacuity Pharmaceuticals Pty Ltd
  • Neurotech Holdings LLC
  • Novelion Therapeutics Inc
  • Ocugen Inc
Note: Product cover images may vary from those shown
Adroll
adroll